GLUE

Monte Rosa Therapeutics, Inc.

3.66 USD
+0.10 (+2.81%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Monte Rosa Therapeutics, Inc. stock is down -13.06% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 3 June’s closed higher than May.

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. engages in the development of novel small molecule precision medicines. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers.